Physician profile
Ketan P Patel
NPI 1003814146
$8,943.73
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,713 · 2020: $117 · 2021: $573 · 2022: $56.93 · 2023: $315 · 2024: $170.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $485.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $484.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biodelivery Sciences International, INC. | $6,590.43 | 2019-2021 | |
| Pulmonx Corporation | $810.10 | 2019 | |
| Kerecis Limited | $330.37 | 2021-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Smith+Nephew, INC. | $271.57 | 2021-2024 | Grafix Pl |
| Organogenesis INC. | $234.67 | 2021-2023 | Puraply |
| Wright Medical Technology, INC. | $154.41 | 2019 | |
| Integra Lifesciences Corporation | $127.66 | 2019 | |
| Kci USA, INC. | $111.14 | 2019 | |
| Nevro Corp. | $109.32 | 2019 | |
| Abbott Laboratories | $56.93 | 2022 | |
| Amarin Pharma, INC. | $48.29 | 2020 | |
| Novartis Pharmaceuticals Corporation | $39.61 | 2019-2021 | |
| Novo Nordisk INC | $38.59 | 2024 | Rybelsus, Ozempic |
| Sunovion Pharmaceuticals INC. | $13.49 | 2020 | |
| Inogen, INC. | $7.15 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ketan Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.